INTRODUCTION
============

Plants, unlike animals, do not possess specialized cells for protection against invading pathogens. When a pathogen challenge is detected, plant defense responses occur through the activation of cellular signal transduction pathways leading to global transcriptional reprogramming. These changes favor immune responses over normal cellular functions ([@gks683-B1],[@gks683-B2]). Equally important is the suppression of immune responses in the absence of a pathogen threat that is necessary for proper plant growth and development. Thus, the induction of defense response to a specific pathogen occurs by a complex signaling network interconnected by crosstalk with networks that regulate response to other stressors, growth and development ([@gks683-B3]). Research on *Arabidopsis thaliana* has demonstrated that local and systemic resistance responses to biotrophic pathogens such as *Pseudomonas syringae* are mediated by the plant hormone salicylic acid (SA). Accumulation of SA leads to reduction of the oligomeric cytoplasmic form of the transcriptional co-activator NPR1/NIM1 (*nonexpressor of PR genes1*) to a monomeric form that translocates to the nucleus ([@gks683-B4; @gks683-B5; @gks683-B6; @gks683-B7; @gks683-B8]). Once there, NPR1 interacts with three redundant transcription factors, TGA2, TGA5 and TGA6 to activate expression of defense genes such as *pathogenesis-related protein 1* (*PR1*) ([@gks683-B9; @gks683-B10; @gks683-B11; @gks683-B12; @gks683-B13]).

Constitutive activation of defense is detrimental to the normal growth of plants ([@gks683-B14; @gks683-B15; @gks683-B16; @gks683-B17]). Therefore, negative regulation of defense responses is very important. Negative regulators of the *PR1* expression and resistance to *P. syringae* include SNI1 (*suppressor of npr1-1, inducible1*), *NIM1-interacting1* and several WRKY transcription factors such as WRKY7, WRKY11 and WRKY17 ([@gks683-B18; @gks683-B19; @gks683-B20; @gks683-B21]). SNI1 was identified in a screen for suppressors of *npr1* ([@gks683-B18]). SNI1 encodes a protein with structural similarity to Armadillo-repeat proteins that are involved in scaffolding or protein--protein interactions. The mechanism by which NPR1 and SNI1 interact to control *PR1* expression is not clear. SA-inducible *PR* gene expression and resistance are restored in the *npr1 sni1* double mutant suggesting that there is an NPR1-independent pathway of SA activation of *PR1* transcription and that NPR1 blocks SNI1 activity. The deoxyribonucleic acid (DNA) recombination protein RAD15 seems to be involved in the regulation of *PR1* expression by the NPR1-independent pathway ([@gks683-B22]). Both SNI1 and RAD51D were found to play roles in *PR* gene transcription and DNA recombination ([@gks683-B22]). Histone modifications are involved in SNI1-mediated repression ([@gks683-B23]).

Calcium signaling is another component of the defense response. Calcium signals are transduced in many ways including the binding of calcium to calmodulins (CaMs) or CaM-like proteins ([@gks683-B24]). The Ca^2+^/CaM complex modulates immune responses by repressing or activating transcription. Transcription of genes involved in SA biosynthesis is modulated by Ca^2+^/CaM ([@gks683-B25]). TGA and WRKY transcription factors are involved in controlling *PR1* expression, and some members of these families of transcription factors are known to bind Ca^2+^/CaM. Details of CaM regulation of defense gene expression are not well-understood.

We show here a novel connection between SNI1 and Ca^2+^/CaM control of *PR1* expression. We demonstrate that a previously identified CaM-binding NAC transcription repressor designated CBNAC ([@gks683-B26]) binds to *cis*-elements on the *PR1* promoter that contain a GCTT core sequence and also interacts physically with SNI1. Genetic analyses showed that CBNAC functions as a negative regulator of pathogen-induced *PR1* expression and basal resistance to a virulent strain of *P. syringae*. CBNAC and SNI1 were found to function synergistically as negative regulators of both *PR1* expression and disease resistance.

MATERIALS AND METHODS
=====================

Plant and bacterial materials
-----------------------------

All *Arabidopsis* plants used in this study were of the Columbia (Col-0) ecotype. The virulent bacterial pathogen, *P. syringae* pv. *tomato* (*Pst*) DC3000 was used for disease response tests. *Escherichia coli* BL21 (DE3) pLysS was used to express and produce recombinant GST-CBNAC protein. *Arabidopsis* transformation was performed as described previously ([@gks683-B27]).

Generation of transgenic plants
-------------------------------

To generate transgenic plants, *CBNAC* complementary DNA (cDNA) with or without the FLAG tag was placed under the control of the *CaMV 35S* promoter. These constructs were cloned into pCAMBIA 1300 and transformed into *Agrobacterium tumefaciens* GV3101. *Arabidopsis* wild-type plants were transformed with the *35S:Flag-CBNAC* construct according to a published protocol ([@gks683-B27]), and T3 progeny lines overexpressing *CBNAC* were selected for experiments. The *35S:CBNAC* construct was used to transform *cbnac1* plants and T3 progeny lines (*cbnac1/CBNAC*) expressing approximately the same level of *CBNAC* as wild-type plants in 1 mM SA-treated leaves were selected for experiments. MS medium containing 40 μg/ml hygromycin was used for selection of transformants.

Plant growth conditions
-----------------------

*Arabidopsis thaliana* plants were grown in growth chambers at 22°C and under 120 μEm^−2^ s^−1^ light intensity and 16-h-light/8-h-dark photoperiod.

Isolation of the *cbnac1* and *cbnac1 sni1* mutant lines
--------------------------------------------------------

The *cbnac1* (Salk_065051) T-DNA insertion mutant was identified from the Salk Arabidopsis T-DNA population ([@gks683-B28]). The T-DNA insertion was confirmed by polymerase chain reaction (PCR) using a T-DNA-specific primer (T-DNA) and a *CBNAC*-specific primer (CBNAC-S). A homozygous *cbnac1* line was identified by PCR using a pair of primers corresponding to T-DNA flanking sequences (F1 and F2). The *sni1* mutant was provided by Dr Xinnian Dong. The *cbnac1 sni1* double mutant was obtained by crossing *cbnac1* and *sni1*, selfing the F1 progeny and screening of the F2 population. The F2 population was screened for an absence of both genes by gene-specific PCR using the following primers: *SNI1*-specific primers (SNI1-S1 and SNI1-S2) and *CBNAC*-specific primers (F1 and F2). The primers used for PCR are listed in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1).

*Pseudomonas* infection
-----------------------

*Pseudomonas* infection was carried out as described previously ([@gks683-B29]). *Pseudomonas syringae* DC3000 (*Pst*DC3000) carrying empty vector (pVSP61) was grown at 28°C on King's agar plates supplemented with 50 μg/ml rifampicin and 50 µg/ml kanamycin. In brief, bacteria were suspended in 10 mM MgCl~2~, adjusted to optical density (OD)~600~ = 0.001 and pressure infiltrated into leaves using a needleless syringe. Leaf discs from four independent plants were combined, ground in 10 mM MgCl~2~, serial-diluted 1:10 and plated onto King's B medium containing the appropriate antibiotics. Plates were incubated at 28°C for 2 or 4 d, after which the colonies were counted.

Quantitative PCR and ribonucleic acid gel blot analysis
-------------------------------------------------------

Total ribonucleic acid (RNA) was isolated using the guanidinium thiocyanate-phenol-chloroform extraction method with subsequent ultracentrifugation ([@gks683-B29]). *Arabidopsis* RNA was extracted using LiCl method, and cDNA was synthesized using the SuperScript™ II RNase-Reverse Transcriptase (Invitrogen). Quantitative PCR (qPCR) was performed using the SsoFast EvaGreen Supermix (Bio-Rad) in a CFX96™ Real-Time PCR System (Bio-Rad). The primers used for qPCR are listed in [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1). Expression of *CBNAC* was detected by RNA gel blot analysis. RNA was separated on 1.5% agarose--formaldehyde gels and transferred to nylon membranes. Membranes were incubated with an (α-^32^P)dATP-labeled gene-specific probe at 65°C overnight and washed under high stringency conditions as described ([@gks683-B29]).

Electrophoretic mobility shift assays
-------------------------------------

For mapping of the CBNAC-binding promoter region of the *PR1* gene, DNA probes were generated by PCR amplification with a Klenow fragment polymerase, α-^32^P-ATP (6000 Ci/mmol; Amersham) and the following primers, for E0, E1, E2, E3, E4, E5, E6, E0-1, E0-2, E0-3, E0-4, E3-1, E3-2, E4-1, E4-2, E4-3, E5-1, E5-2, E6-1 and E6-2 and by end labeling with polynucleotide kinase, γ-^32^P-ATP and the following primers, for E0-1-1, E0-1-2, E0-4-1, E0-4-2, E3-1-1, E3-1-2, E3-1-3, E4-1-1, E4-1-2, E5-3-1, E5-3-2, E6-1-1 and E6-1-2 ([Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). DNA-binding reactions were conducted at 25°C for 20 min in binding buffer \[20 mM HEPES/KOH (pH 7.9), 0.5 mM DTT, 0.1 mM ethylenediaminetetraacetic acid (EDTA)\], 50 mM KCl, 15% glycerol, 1 μg poly(dI-dC) and 0.5 μg bacterially produced fusion protein purified with glutathione-Sepharose. ^32^P-labeled DNA probes (40 000 cpm) were added and incubated with the mixture at 25°C for 30 min. The reactions were separated on an 8% polyacrylamide gel in 0.5× tris-borate-EDTA buffer at 80 V for 3 h. The gel was dried, mounted for autoradiography with intensifying screens and exposed at --70°C.

Chromatin immunoprecipitation assay
-----------------------------------

Chromatin samples were prepared as described previously ([@gks683-B30]). Wild-type and *35S:Flag*-CBNAC overexpression lines were fixed with 1% formaldehyde for 10 min. The eluted DNA was analyzed by PCR using the following specific primers: E0, E3, E4, E5 and E6 ([Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). The amplified bands were visualized on a 2% agarose gel.

Yeast two-hybrid assay
----------------------

*CBNAC* cDNA was digested with EcoRI and XhoI and ligated into the pAS2-1 plasmid (bait vector), which contains the *Trp1* selection marker. The *SNI1* cDNA was cloned into the pGAD424 plasmid (prey vector), which harbors the *Leu2* selection marker. For mapping, the interacting domain deletions of CBNAC were PCR amplified using gene-specific primers and cloned in the pAS2-1 plasmid. Prey and different bait plasmids were co-transformed in the pJ69-4A ([@gks683-B31]) strain of yeast. Two-hybrid assays were performed as described in CLONTECH's Yeast Protocols. Positive interactions were verified by the β-galactosidase assay.

Luciferase complementation imaging assay
----------------------------------------

Luciferase (Luc) complementation imaging (LCI) assay was carried out as described previously ([@gks683-B32]). CBNAC was fused with the C-terminal fragment of firefly Luc in pCAMBIA NLuc vector (CLuc-CBNAC). SNI1 was fused with the N-terminal fragment of Luc in pCAMBIA NLuc vector (SNI1-NLuc). STG1a-NLuc and CLuc-RAR1 constructs described previously were used as positive interaction controls ([@gks683-B32]). The constructs were each introduced into *A. tumefaciens* strain GV3101. Each bacterial strain was grown overnight in LB medium at 30°C, collected by centrifugation, then washed two times with infiltration buffer (10 mM MgCl~2~, 10 mM MES and 100 μM acetosyringone) and re-suspended in the same buffer. Equal volumes of bacterial suspensions of a CLuc and an NLuc construct were mixed and co-infiltrated into fully expanded leaves of the 3-week-old *Nicotiana benthamiana* plants using a needleless syringe. After infiltration, plants were placed at 23°C for 48 h. *Pst*DC3000 (OD~600~ = 0.001 in 10 mM MgCl~2~) was treated after 24 h as Agro infiltration. The leaves were sprayed with luciferin solution (100 μM luciferin, 0.1% Triton X-100) and kept in the dark for 4 h to quench fluorescence. Luc activity (luminescence) was observed with a low-light cooled CCD imaging apparatus (AndoriXon; Andor).

RESULTS
=======

*CBNAC* transcripts are induced by pathogen and SA treatment
------------------------------------------------------------

To identify the biological function of CBNAC, we investigated the gene expression of *CBNAC* in response to environmental stresses. The transcript level of *CBNAC* was examined after exposure to several biotic and abiotic stresses including bacterial pathogen, SA, jasmonic acid (JA), ABA, drought and NaCl. Interestingly, *CBNAC* transcript levels were increased in leaves of wild-type *Arabidopsis* plants after exposure to the virulent bacterial pathogen *Pst*DC3000 or SA ([Figure 1](#gks683-F1){ref-type="fig"}). *CBNAC* transcripts were undetectable in untreated leaves and remained undetectable over a 48-h period in leaves after infiltration with 10 mM MgCl~2~. In leaves infiltrated with *Pst*DC3000, significant accumulation of *CBNAC* transcripts was observed at 6--12 h post-inoculation, and it returned to an undetectable level by 24 h ([Figure 1](#gks683-F1){ref-type="fig"}A). Expression of *CBNAC* was also induced by SA, the inducer of systemic acquired resistance ([Figure 1](#gks683-F1){ref-type="fig"}B). In SA-treated leaves, *CBNAC* transcripts reached maximum levels at 6 h, persisted for 24 h and declined to basal levels 48 h after treatment. These results suggested that CBNAC may be involved in SA-mediated pathogen resistance signaling in plants. Figure 1.*CBNAC* expression is induced by pathogen- and SA. (**A**) Induction of CBNAC gene expression by *Pst*DC3000. Leaves of 4-week-old *Arabidopsis* plants (Col-0) were infiltrated with a bacterial suspension (OD~600~ = 0.001 in 10 mM MgCl~2~). Infitrated leaves were harvested at the indicated times after inoculation. The gel blot analysis of total RNA that was performed with a ^32^P-labeled *CBNAC* probe is shown. Ethidium bromide-stained *rRNA* is shown as loading control. (**B**) Induction of *CBNAC* gene expression by SA. Leaves of 4-week-old *Arabidopsis* plants (Col-0) were treated with 1 mM SA. Leaf collection, RNA isolation and RNA gel blot analysis was performed as in (A).

CBNAC is a negative regulator of the plant defense
--------------------------------------------------

The following genetic resources were developed for investigation of CBNAC function *in vivo*. A Salk line (Salk_065051) carrying a T-DNA insertion in *CBNAC* (*cbnac1*) was identified and homozygous F2 progeny derived from this line were used for analyses. Location of the T-DNA insertion at the third exon of the *CBNAC* gene was confirmed by PCR analyses of genomic DNA ([Supplementary Figure S1A](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). There was no detectable accumulation of *CBNAC* transcripts in untreated leaves of the wild-type and *cbnac1* mutant plants. Complete loss of *CBNAC* expression was revealed by comparing the transcript abundance in SA-treated leaves of wild-type and *cbnac1* plants ([Supplementary Figure S1B](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). Attempts to identify additional independent *cbnac* mutants were unsuccessful. Thus, a *35S:CBNAC* construct was used to transform the *cbnac1* mutant, and transgenic lines (*cbnac1*/*CBNAC*) exhibiting *CBNAC* expression levels similar to wild-type plants were chosen for complementation analysis ([Supplementary Figure S2A](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). Transgenic lines constitutively overexpressing *CBNAC* (*35S:Flag*-CBNAC) were generated in the wild-type background. Western blot analysis using anti-FLAG antibody revealed several transgenic plants contained elevated levels of CBNAC protein regardless of SA treatment ([Supplementary Figure S1C](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)).

There were no obvious differences in growth or development characteristics of the wild-type, *cbnac1* or *35S:Flag-CBNAC* plants. The effect of CBNAC expression level on susceptibility to the virulent bacterial pathogen *Pst*DC3000 was then examined. Three days after inoculation, bacterial growth in infiltrated leaves was slightly lower in the null *cbnac1* mutant and slightly higher in *35S:Flag-CBNAC* overexpression lines compared with the wild type ([Figure 2](#gks683-F2){ref-type="fig"}A). There was no significant difference in bacterial growth in leaves of the wild-type plant and a *cbnac1*/*CBNAC* complementation line ([Supplementary Figure S2B](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). As loss of *CBNAC* function is associated with resistance and overexpression of *CBNAC* is associated with susceptibility in un-induced plants, CBNAC is a negative regulator of basal defense against the bacterial pathogen *Pst*DC3000.

Induction of *PR1* is a marker of SA-mediated defense signaling that leads to *Arabidopsis* resistance to bacterial pathogens ([@gks683-B2]). *PR1* transcript accumulation was not observed in leaves of wild-type, *cbnac1, cbnac1*/*CBNAC* or *35S:Flag-CBNAC* plants before inoculation with *Pst*DC3000 ([Figure 2](#gks683-F2){ref-type="fig"}B and [Supplementary Figure S2C](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). At 12 h post-inoculation when the expression of *CBNAC* was expected to peak in wild-type plants ([Figure 1](#gks683-F1){ref-type="fig"}A), accumulation of *PR1* transcript was significantly suppressed in *35S:Flag-CBNAC* plants, induced in the *cbnac1* mutant and unchanged in the *cbnac1*/*CBNAC* complementation line in comparison with wild type ([Figure 2](#gks683-F2){ref-type="fig"}B and [Supplementary Figure S2C](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). Thus, the level of *CBNAC* expression correlates inversely with resistance to pathogen infection and *PR1* expression, suggesting that *PR1* may be a direct target of CBNAC. Figure 2.*CBNAC* negatively regulates resistance to *Pst*DC3000 and *PR1* expression. Leaves of wild type (WT), 35S:*Flag-CBNAC* and *cbnac1* plants were inoculated with a bacterial suspension (OD~600~ = 0.001 in 10 mM MgCl~2~). (**A**) Growth of *Pst*DC3000 in inoculated leaves at 0 and 3 dpi. Mean bacterial densities ± SE were calculated from six to eight replicate plants are shown. Significant differences as calculated by Student's *t* test (*P* \< 0.05) are indicated by unique letters. The experiment was repeated at least three times with similar results. (**B**) qRT-PCR analysis of *PR1* expression in inoculated leaves. Values were normalized using the expression level of *Tubulin 2* and expressed relative to the expression level in WT at 12 hpi, which is arbitrarily set at 100. Mean relative expression values ± SE from three independent experiments are shown. Data were analyzed by Student's *t* test. Different letters indicate statistically significant differences between genotypes (*P* \< 0.05).

CBNAC binds to the *PR1* promoter by a GCTT core element
--------------------------------------------------------

In *cbnac1* knockout plants, the levels of *PR1* transcripts were higher compared with those in wild-type plants. To examine whether this effect was attributable to direct binding of the CBNAC to the *PR1* promoter, we investigate the direct interaction of CBNAC to the PR promoter by electrophoretic mobility shift assays (EMSA). EMSA using recombinant GST-CBNAC fusion protein and *PR1* promoter fragments up to 1041-bp upstream of the *PR1* start codon were used to demonstrate that CBNAC protein can bind to the *PR1* promoter. Using seven ∼110-bp overlapping fragments of the *PR1* promoter sequence ([Supplementary Figure S3A](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)), five regions (E0, E3, E4, E5 and E6) were found to bind to CBNAC ([Supplementary Figure S3B](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)).

Within the five regions, smaller overlapping fragments (∼52 bp) were used to define the specific target of CBNAC ([Supplementary Figure S4A](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). Six regions (E0-1, E0-4, E3-1, E4-1, E5-3 and E6-1) demonstrated binding to CBNAC ([Supplementary Figure S4B](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). Overlapping oligonucleotides within the E0-1, E0-4, E3-1, E4-1, E5-3 and E6-1 fragments were used to further delineate CBNAC-binding sequences ([Supplementary Figure S5A](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). CBNAC bound six *PR1* promoter fragments ([Supplementary Figure S5B](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1) and [Table 1](#gks683-T1){ref-type="table"}). Of these, E0-1-1 exhibited very strong CBNAC binding. E0-4-2, E3-1-2 and E5-3-1 had moderate affinity. The two remaining elements, E4-1-1 and E6-1-1, bound very weakly. The E0-1-1 and E0-4-2 fragments contain the GCTT core sequence that was previously identified as a CBNAC-binding sequence by the random binding site selection method ([@gks683-B26]). E3-1-2 has been previously identified as a negative regulatory element on the *PR1* promoter ([@gks683-B12]). Table 1.Putative CBNAC-binding *cis*-acting elements in the *PR1* promoter*cis* elementSequence[^a^](#gks683-TF1){ref-type="table-fn"}Position[^b^](#gks683-TF2){ref-type="table-fn"}Binding affinity[^c^](#gks683-TF3){ref-type="table-fn"}E0-1-1TAATAAT[GCTT]{.ul}AGTTATAAATTACT(--) 1209 ∼ (--) 1185+++E0-4-2TGTTATT[GCTT]{.ul}AGAATCACAGATTC(--) 994 ∼ (--) 970++E3-1-2CTATTGACTGTTTCTCTACGTCACTATT(--) 715 ∼ (--) 688++E4-1-1ATACTCATATGCATGAAACACTAAGAAAC(--) 618 ∼ (--) 590+E5-3-1ATATACAATGTTTCTTAATAAACTTCATTT(--) 340 ∼ (--) 311++E6-1-1AAAAAAATATATCAACAATGGCAAAGCT(--) 288 ∼ (--) 261+[^2][^3][^4]

Interactions between CBNAC and the E0-1-1 element were further analyzed. [Figure 3](#gks683-F3){ref-type="fig"}A depicts the four mutant E0-1-1 elements (M1--M4) used in the EMSA. As shown in [Figure 3](#gks683-F3){ref-type="fig"}B, CBNAC bound strongly and specifically with radiolabeled E0-1-1. A mobility shift was not observed on incubation of the labeled E0-1-1 element with GST alone. Furthermore, addition of unlabeled E0-1-1 element inhibited binding of labeled E0-1-1 to CBNAC in a concentration-dependent manner ([Figure 3](#gks683-F3){ref-type="fig"}B). Compared with the interaction of CBNAC with E0-1-1, its binding with M1 was weaker and was almost negligible with M2, M3 and M4 ([Figure 3](#gks683-F3){ref-type="fig"}C). These results indicated that the GCTT core sequence of E0-1-1 is critical for CBNAC binding. Figure 3.CBNAC interacts with the E0-1-1 element of the *PR1* promoter. (**A**) Nucleotide sequence of the native and mutated (M1--M4) E0-1-1 elements used in EMSA. (**B**) Analysis of binding specificity. EMSA was performed using ^32^P-labeled native E0-1-1 as probe as above except that GST-CBNAC protein was preincubated with 50- (lane 4), 100- (lane 5) or 200- (lane 6) fold molar excess of cold native E0-1-1 (competitor) before addition of probe. (**C**) EMSA of CBNAC binding. ^32^P-labeled native (lanes 1--3) and mutated (lanes 4--7) E0-1-1 probes were incubated with equal amounts of *E. coli*-expressed GST-CBNAC (lanes 3 to 7) or GST alone (lanes 1 and 2) before electrophoresis.

Chromatin immunoprecipitation (ChIP) experiments were then used to determine whether CBNAC binds the *PR1* promoter *in vivo*. In these experiments, cross-linked chromatin from leaves of wild-type and *35S:Flag*-CBNAC plants were incubated with FLAG-specific monoclonal antibodies enriching for CBNAC and *PR1* promoter complexes. The five *PR1* promoter regions shown to bind CBNAC *in vitro* (E0, E3, E4, E5 and E6) were then amplified with specific primers. Three independent ChIP experiments were performed, and representative results from a single assay are shown ([Supplementary Figure S5C](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). PCR analyses of input chromatin samples verified that similar quantities of ChIP starting materials were used for each primer pair. As expected, immunoprecipitation reactions lacking anti-FLAG antibody did not result in the recovery of chromatin fragments containing the *PR1* promoter ([Supplementary Figure S5C](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1), No Ab). Only the E0 (--1209 to --970 bp) region was amplified in immunoprecipitates obtained with anti-FLAG antibody ([Supplementary Figure S5C](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1), α-Flag Ab), confirming that CBNAC directly binds to a region of the *PR1* promoter that contains the GCTT core sequence.

CBNAC physically interacts with SNI1
------------------------------------

Similar to CBNAC, SNI1 is a negative regulator of *PR1* expression. However, unlike CBNAC, SNI1 does not have a DNA-binding domain. Therefore, the possibility of interaction between CBNAC and SNI1 was examined in a yeast two-hybrid assay. The bait construct (pAS2-1::*CBNAC*) contained full-length *CBNAC* cDNA fused to the GAL4 DNA-binding domain. The prey construct (pGAD424::*SNI1*) contained full-length *SNI1* cDNA fused to the GAL4 activation domain. As shown in [Figure 4](#gks683-F4){ref-type="fig"}A, yeast cells expressing either bait or prey construct alone were not able to grow on selection media. Growth on selective medium and expression of the *LacZ* reporter gene was observed only if yeast contained both pAS2-1::*CBNAC* and pGAD424::*SNI1*, indicating specific interaction between CBNAC and SNI1.

Interaction of CBNAC with SNI1 *in planta* was then examined using the LCI assay in *N. benthamiana* leaves using transient expression ([@gks683-B32]). The positive control combination of STG1a-NLuc and CLuc-RAR1 resulted in strong Luc activity as previously reported ([@gks683-B32]) ([Figure 4](#gks683-F4){ref-type="fig"}B). The negative control combinations of CLuc-CBNAC/NLuc vector and SNI1-NLuc/CLuc vector did not show Luc activity ([Figure 4](#gks683-F4){ref-type="fig"}B). Luc activity was detected with the combination of SNI1-NLuc/CLuc-CBNAC showing that CBNAC interacts with SNI1 *in planta*. Figure 4.CBNAC interacts with SNI1. (**A**) Yeast two-hybrid analysis. Transformants of yeast strain pJ69-4A were grown as indicated (upper left) on minimal medium with (+Ade) or without (--Ade) selection. Adenine prototrophy indicates positive interaction. β-Galactosidase activity in the colonies grown in +Ade medium was determined by filter-lift assay (LacZ). (**B**) LCI assay for detecting interaction *in planta*. Tobacco leaves were transformed by *Agrobacterium* infiltration using a needleless syringe. The indicated NLuc and CLuc construct pairs were used for transformation. Shown are luminescence images (upper panel) and quantitative luminescence measurements (lower panel) depicting luciferase activity in inoculated leaves at 48 hpi.

Additional yeast two-hybrid assays were performed to define the CBNAC domain responsible for interaction with SNI1. A schematic diagram of the CBNAC deletion constructs used for these assays is shown in [Supplementary Figure S6A](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1). The NAC domain of CBNAC was not required for interaction with SNI1 ([Supplementary Figure S6B](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). The C-terminal region (301--512 amino acids) of CBNAC interacted with SNI1. The interaction between CBNAC and SNI1 required the CaM-binding domain as well as other sequences.

CBNAC and SNI1 function synergistically as negative regulators of disease resistance
------------------------------------------------------------------------------------

A *cbnac1 sni1* double mutant was generated through genetic crossing and analyzed for potential interactions between *CBNAC* and *SNI1*. Morphological phenotypes of the *cbnac1 sni1* mutant resembled those of the *sni1* mutant rather than the *cbnac1* mutant. Both *sni1* and *cbnac1 sni1* plants had smaller rosettes compared with the wild type ([Figure 5](#gks683-F5){ref-type="fig"}A). Similar to the *sni1* mutant, *cbnac1 sni1* plants exhibited pleiotropic phenotypes, including decreased leaf size and altered leaf texture ([Figure 5](#gks683-F5){ref-type="fig"}A and B). In contrast, the *cbnac1* plants showed no differences in growth, development or morphology in comparison with the wild type ([Figure 5](#gks683-F5){ref-type="fig"}A and B). As shown in [Figure 5](#gks683-F5){ref-type="fig"}C, the *cbnac1* and *sni1* mutants had similar levels of basal resistance to *Pst*DC3000 ([Figure 5](#gks683-F5){ref-type="fig"}C). Bacterial counts in inoculated leaves of both lines were slightly lower than in leaves of the wild type 3 days post-inoculation. Disease symptoms were also less severe in the *cbnac1* and *sni1* mutants than in wild-type leaves ([Figure 5](#gks683-F5){ref-type="fig"}B). The *cbnac1 sni1* double mutant was markedly more resistant to *Pst*DC3000 than either the *cbnac1* or *sni1* single mutants ([Figure 5](#gks683-F5){ref-type="fig"}C). Bacterial counts in inoculated leaves of the *cbnac1 sni1* mutant were 10-fold lower than in leaves of the wild type at 3 days post-inoculation. This marked reduction in bacterial growth in inoculated leaves of the *cbnac1 sni1* mutant compared with the *cbnac1* or *sni1* mutants was accompanied by the substantially reduced disease symptom development ([Figure 5](#gks683-F5){ref-type="fig"}B). Figure 5.Altered responses of the *cbnac1 sni1* double mutant to *Pst*DC3000. (**A**) Morphology of 5-week-old wild-type (WT), *cbnac1*, *sni1* and *cbnac1 sni1* plants grown on MS agar plates. (**B--D**) Disease resistance responses in leaves inoculated with bacterial suspension as in [Figure 3](#gks683-F3){ref-type="fig"}. Disease symptoms in inoculated leaves at 5 dpi are depicted (B). Bacterial growth in inoculated leaves at 0 and 3 dpi are compared (C). Mean bacterial densities ± SE were calculated from six to eight replicate plants. Significant differences as calculated by Student's *t* test (*P* \< 0.05) are indicated by unique letters. The experiment was repeated at least three times with similar results. *PR1* expression was monitored in inoculated leaves by qRT-PCR (D). Values were normalized using the expression level of *Tubulin 2* and expressed relative to the expression level in WT at 12hpi, which is arbitrarily set at 100. Mean relative expression values ±SE values from three independent experiments are shown. Data were analyzed by Student's *t* test. Different letters indicate statistically significant differences between genotypes (*P* \< 0.05).

To investigate the enhanced basal resistance of the double mutant, *PR1* expression was analyzed following bacterial pathogen infection. The level of *PR1* mRNA was comparable in uninoculated leaves of wild type and *cbnac1* plants ([Figure 5](#gks683-F5){ref-type="fig"}D). SNI1 has been reported to repress basal *PR1* expression ([@gks683-B18]). Accordingly, the level of *PR1* mRNA was higher in uninoculated leaves of the *sni1* mutant than in wild type. At 12 h post-inoculation, *PR1* transcript abundance was elevated in the *cbnac1* and *sni1* mutants compared with wild type, as expected if they function as transcriptional repressors. The *PR1* levels in uninoculated and inoculated leaves of the *cbnac1 sni1* double mutant were significantly higher than in leaves of *cbnac1* or *sni1* single mutants under the same condition, suggesting a synergistic effect of the combined *cbnac1* and *sni1* mutations on *PR1* expression ([Figure 5](#gks683-F5){ref-type="fig"}D). Together, these results show that *CBNAC* and *SNI1* function synergistically as negative regulators of basal resistance to the virulent bacterial pathogen *Pst*DC3000 due, in part, to their overlapping activities as negative regulators of *PR1* expression.

SNI1 enhances the DNA-binding activity of the CBNAC
---------------------------------------------------

Although *SNI1* functions as a transcriptional repressor of *PR1* expression, it lacks a DNA-binding domain ([@gks683-B23]). Therefore, the possibility that SNI1 could influence the DNA-binding activity of CBNAC toward the *PR1* promoter *cis*-element (E0-1-1) was investigated because SNI1 interacts with CBNAC.

The *PR1* promoter element (E0-1-1), previously identified by EMSA, contains the preferred GCTT core binding sequence for CBNAC ([Figure 6](#gks683-F6){ref-type="fig"}A). Incubation of SNI1 with the E0-1-1 probe did not result in a retarded band in an EMSA ([Figure 6](#gks683-F6){ref-type="fig"}B, lane 3) indicating that SNI1 does not directly bind to this element. Addition of SNI1 to the CBNAC-binding mixture increased CBNAC binding to the E0-1-1 element without producing a supershift band, indicating that the DNA--protein complex contained CBNAC but not SNI1 ([Figure 6](#gks683-F6){ref-type="fig"}B, lanes 5 and 4). These results suggested that SNI1 enhances the binding of CBNAC to the E0-1-1 element. Figure 6.SNI1 enhances binding of CBNAC to the E0-1-1 element. (**A**) Nucleotide sequence of the *PR1* promoter indicating E0-1-1 element. The numbers indicate the position of the element relative to the *PR1* translation start site. (**B**) EMSA analysis of the effect of SNI1. EMSA was performed using ^32^P-labeled E0-1-1 element (lanes 1 to 5), without (lane 1) or with the addition GST (lane 2; negative control), CBNAC (lanes 4 and 5) and SNI1 (lane 5). Equal amounts of CBNAC were used in the two lanes.

DISCUSSION
==========

CBNAC acts as a negative regulator of plant defense responses
-------------------------------------------------------------

Discrepancies exist in several studies that had reported on the biochemical properties of CBNAC/NTL9 ([@gks683-B26],[@gks683-B33]). First, CBNAC/NTL9 had been reported to contain a C-terminal transmembrane domain and that CBNAC/NTL9 was localized in the plasma membrane ([@gks683-B33]). However, the predicted C-terminal transmembrane domain of CBNAC/NTL9 was identified as a CaM-binding domain ([@gks683-B26]). Furthermore, the GFP-tagged CBNAC/NTL9 protein was considered to be dominantly localized in nuclei ([@gks683-B26]). Finally, on a different level of function, CBNAC/NTL9 was reported to be involved in regulating signaling during leaf senescence ([@gks683-B33]). The biological function of CBNAC/NTL9 was based on the phenotypes of transgenic plants overexpressing the C-terminal truncated form of CBNAC/NTL9, but the *cbnac1/ntl9-1* mutant and transgenic plants overexpressing the full-length CBNAC/NTL9 did not exhibit any phenotypes. It seems likely that the biological function of CBNAC/NTL9 could be misinterpreted from the phenotypes reported for transgenic plants overexpressing CBNAC/NTL9 devoid of its regulatory domain. In essence, the physiological function of CBNAC/NTL9 has not been elucidated to sufficient detail.

CBNAC is a CaM-binding transcriptional repressor that interacts with DNA through a GCTT core sequence flanked on both sides by frequently repeating sequences ([@gks683-B26]). This study demonstrates CBNAC binds to the promoter of *PR1*, a marker gene for SA-induced defense responses and also inhibits pathogen-induced increase in *PR1* expression. CBNAC alone, and in synergism with SNI1, negatively regulates basal resistance to *Pst*DC3000. As CaM regulates the repressor function of CBNAC ([@gks683-B26]), these results imply that CBNAC is a point of crosstalk between calcium- and SA-mediated defense signaling.

Linker-scanning (LS) mutagenesis of the *PR1* promoter revealed at least three *cis*-elements (*LS5*, *LS7* and *LS10*) displaying positive or negative characters ([@gks683-B34]). *LS5* and *LS7* both contain the binding sequence (TGACG) for TGA transcription factors and TGA2 independently binds the *LS5* and *LS7* promoter elements *in vitro* ([@gks683-B10]). The *LS5* element seems to contribute to the negative regulation of *PR1* expression both in the absence and presence of SA, whereas *LS7* is required for SA-mediated *PR1* induction ([@gks683-B34]). The GCTT *cis*-element for CBNAC binding to the *PR1* promoter represents a novel *PR1* regulatory module. Interestingly, CBNAC is recruited to the *PR1* promoter in both non-treated and SA-treated tissues ([Supplementary Figures S5C](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1) and [S7](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). SA-independent binding of CBNAC to the *PR1* promoter suggests that the DNA-binding activity of CBNAC is not altered by SA.

Both *Pst*DC3000 and SA induced *CBNAC* quickly in a transient way ([Figure 1](#gks683-F1){ref-type="fig"}). The induction of the negative regulator during the early stages of infection might serve as a mechanism to prevent gratuitous or even harmful overactivation of pathogen-induced defense mechanisms when the population of the pathogen remains at relatively low levels ([@gks683-B35]). As pathogen growth increases, enhanced defense mechanisms would be necessary, and this could be achieved at least partially by suppressed expression and inactivation of negative regulators such as CBNAC and WRKY factors.

Pathogen-induced expression of negative defense regulators could be explained by their involvement in the antagonistic crosstalk of distinct signaling pathways against various types of microbial pathogens. SA-mediated signaling activates defense mechanisms effective against biotrophic pathogens but can suppress ET/JA-mediated signaling in defense against necrotrophic pathogens ([@gks683-B3]). For example, overexpression of the transcription factor WRKY33 enhances susceptibility to the biotrophic pathogen *Pst*DC3000 and increases resistance to necrotrophic fungal pathogens ([@gks683-B36]). *cbnac1* plants showed enhanced resistance to biotrophic pathogen *Pst*DC3000 but no difference to necrotrophic fungal pathogens. Consistently, the transcription levels of JA-responsive marker genes, *PDF1.2* and *LOX2*, were similar in *cbnac1* mutant and wild-type plants ([Supplementary Figure S8](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). These results suggest that CBNAC is not involved in the antagonistic crosstalk of defense signaling pathways against biotrophic and necrotrophic pathogens. It is possible that CBNAC is involved in crosstalk between SA- and NPR1-mediated defense signaling and as yet unidentified environmental stress signaling.

CBNAC acts synergistically with SNI1 as a transcriptional repressor of the *PR1* gene
-------------------------------------------------------------------------------------

SNI1, a transcriptional repressor of *PR* gene expression, has no apparent DNA-binding domain and is predicted to bind to DNA indirectly by interactions with DNA-binding proteins ([@gks683-B23]). CBNAC has been identified as one DNA-binding protein that interacts with SNI1 ([Figure 5](#gks683-F5){ref-type="fig"}). SNI1 enhances the DNA-binding activity of CBNAC to a *PR1* promoter element ([Figure 6](#gks683-F6){ref-type="fig"}B). There are several reported instances where an interaction partner enhances or inhibits DNA-binding activity of a transcription factor. The human viral protein TAX stimulates the DNA binding of bZIP proteins ([@gks683-B37]), whereas *Arabidopsis* NPR1 stimulates the DNA binding of TGA factors to the LS7 element ([@gks683-B10]). The tobacco ankyrin repeat protein ANK1 inhibits the binding of the bZIP factor BZI-1 to its cognate promoter element in EMSA without altering the complex mobility ([@gks683-B38]). Similarly, SNI1 enhanced the binding of CBNAC to its cognate promoter element in EMSA without altering the complex mobility ([Figure 6](#gks683-F6){ref-type="fig"}B). There are two possible explanations. First, SNI1 may have been released from the complex by a conformational change resulting from CBNAC binding to DNA. Second, other interacting proteins may be required for a stable interaction between CBNAC and SNI1.

Model for *PR1* regulation
--------------------------

Based on the information generated in this and previous studies, the following model is proposed ([Figure 7](#gks683-F7){ref-type="fig"}). The *PR1* promoter contains both positive TGA-binding (TGACG) and negative CBNAC-binding (E0-1-1) elements. Genetic analyses showed that *CBNAC* interacts synergistically with *SNI1* as a transcriptional repressor of *PR1* gene expression and basal resistance to *Pst*DC3000 ([Figure 5](#gks683-F5){ref-type="fig"}C and D). Unlike *cbnac1* plants, *sni1* and *cbnac1 sni1* plants exhibit constitutive *PR* gene expression and other pleiotropic phenotypes ([Figure 5](#gks683-F5){ref-type="fig"}A). Therefore, in absence of pathogen induction, SNI1 is proposed to function as the major negative regulator of *PR* gene expression whose activity is governed, in part, by its interaction with the transcriptional repressor CBNAC at the E0-1-1 element. The constitutive binding of transcriptional activators (such as TGA1, TGA3 and TGA6) to the positive element in a non-induced state is still a possibility. However, this binding would not lead to gene expression in the presence of CBNAC and SNI1. Figure 7.Model for the regulation of *PR1* by the CBNAC-SNI1 complex. In non-induced conditions (--Pathogen), because SNI1 does not contain a known DNA-binding domain, we postulate that SNI1 binds to CBNAC and is thereby recruited the E0-1-1 element of *PR1* promoter. SNI1 enhances the DNA-binding activity of CBNAC and somehow this enhances repression of *PR1* by SNI1. In the presence of inducer (+Pathogen), *PR1* gene expression is induced by the translocation of a large amount of active NPR1 to the nucleus and its interaction with TGA transcription factors. The SNI1/CBNAC protein complex can be removed by NPR1, CaM or other unknown mechanisms.

On pathogen infection, transcription of *PR1* is activated and repression is terminated. Transcriptional activation of *PR1* by NPR1 is well characterized and is mediated by its association with the positive TGA transcription factors. However, mechanisms by which repression of *PR1* expression are terminated following pathogen infection are poorly understood. On the basis of the data presented herein, three possibilities can be considered. First, CBNAC and SNI1 could be degraded by a pathogen signal, but there is no strong evidence in support of this hypothesis. Second, CBNAC and SNI1 could be removed by the binding of other regulator proteins or by covalent modifications because the interaction between CBNAC and SNI1 is reduced or removed by pathogen treatment ([Supplementary Figure S9](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). CaM could also be involved in the termination of transcriptional repression through the *PR1* promoter E0-1-1 element because CaM interacts with CBNAC ([@gks683-B26]), and the CaM-binding domain of CBNAC is required for interaction with SNI1 ([Supplementary Figure S6](http://nar.oxfordjournals.org/cgi/content/full/gks683/DC1)). This scenario is rendered likely because influx of Ca^2+^ followed by the activation of Ca^2+^/CaM signaling processes represents early and essential events in the response to pathogen infection ([@gks683-B39],[@gks683-B40]). Several CaM-binding proteins have already been shown to be involved in plant defense responses ([@gks683-B41],[@gks683-B42]). Third, CBNAC and SNI1 repression is removed by NPR1. It has been proposed that the role of NPR1 in a wild-type plant is to inactivate SNI1-mediated transcriptional repression of *PR* genes ([@gks683-B18]). As such, *PR* gene expression is restored and is inducible in the *sni1 npr1-1* double mutant. However, a physical interaction between SNI1 and NPR1 has never been demonstrated so it is unclear whether NPR1 regulates the SNI1 repression of *PR* genes. Further molecular and genetic studies are required to precisely characterize the regulatory mechanisms that converge on the *PR1* gene, resulting in the precise control of *PR1* expression in response to environmental stimuli.
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